Advertising & Editorial Information

For more information about advertising and editorial opportunities, please contact us here.

Advertising Opportunities

Advertising Opportunities

At European Pharmaceutical Review we offer a range of print and online advertising opportunities suited to all our customers needs. Our magazine and website are accessed by senior managers and key decision-makers in the pharmaceutical, life sciences and drug discovery industries, predominantly across Europe, but also in the United States. Typical job titles include Managing Directors, Procurement Directors, Heads of R&D, Senior Scientists, Laboratory Managers, Process Engineers, Chief Engineers, Production Directors, Plant Managers, Product Managers, Quality Assurance Managers and Quality Control Managers. Pharmaceutical manufacturers are a core component of our readership. This represents a highly targeted advertising opportunity for companies, who wish to influence the key decision makers in what is a vitally important industry.

Download our latest media planner  


Reaching Your Audience

With industry events being cancelled and travel restrictions being put upon both companies and individuals, reaching your audience at this time has never been more difficult. This is where European Pharmaceutical Review can help you in reaching your audience and optimising your marketing budget.

Read more


Key Statistics

Print magazine circulation12,000
Additional unique digital circulation11,742
Email Third Party subscribers34,435
Email Industry Insight subscribers41,857
Email Enewsletter subscribers35,005
Twitter followers [View Profile]13,890
LinkedIn company page followers [View Profile]32,065
LinkedIn group members [View Profile]2,742
Facebook followers [View Profile]3,304
Website average monthly unique users August 2021 – August 2022126,902
Website average monthly page views August 2021 – August 2022172,267

Figures correct as of 13 September 2022

Brand Awareness

Strategically position your brand within the European Pharmaceutical Review network to put yourself in front of leaders in the pharmaceutical industry. With an audience of 11,742 print magazine readers, 35,005 opt-in enewsletter subscribers and 126,902 average unique monthly website visitors, our brand awareness opportunities enable you to reach valuable prospects, capture mindshare and encourage direct response. European Pharmaceutical Review offers a range of integrated marketing opportunities and a variety of campaign elements — print and digital ads, events, social media and more — that can be customised to meet your business goals.

Thought Leadership

Partner with European Pharmaceutical Review to showcase your expertise to elite pharmaceutical professionals. We will work alongside your marketing team to develop a multi-channel plan and create content that communicates your thought leadership, resonates in the marketplace and reaches your target audience. Distributing content through our unique network maximizes your reach, reinforces your position as a go-to provider and strengthens your influence within the market.

Lead Generation

Highlight your product via direct response campaigns within the European Pharmaceutical Review network to educate prospects, drive engagement and secure business development opportunities. We will partner with you to identify the optimum mix of channels to deliver your message through a range of touch points — in-person at events, web and online communications, and more — to reach your business goals. Delivering tailored communications under the European Pharmaceutical Review brand to our engaged audience is critical to a successful lead generation campaign and helping you gather your Marketing Qualified Leads.

Tech Specs

Advertising Technical Specifications

Technical specifications for all advertising channels (print & digital) can be found here:

Author Information

How to contribute

Every issue of European Pharmaceutical Review contains the highest quality articles from leading sources, recognised for their expertise within specific areas of the industry. All of our articles are commissioned directly from the world’s leading pharmaceutical companies and academic institutions.

If you have read our publishing schedule or a recent issue of European Pharmaceutical Review and feel that you can match the standard of editorial and have an interesting project, opinion or background to share with our readers, please contact the Editor, Caroline Peachey.

Notes for authors


Articles should be written in the English language.


Please avoid commercial bias in the article. Only refer to individual products/processes if it is essential to support the technical content of the text.

Word count

Unless stated otherwise, your article should be between 1,200 and 1,500 words in length, not including captions or references.


References should be numbered throughout the article and fully listed at the end of the article .

Images, graphs and tables

Any images/photos/graphics to illusrate the article must be high resolution: at least 300 dpi and saved in either a JPEG or TIFF format as separate files, not embedded in a MS Word document or similar.

Author’s biography & photograph

Please supply a brief biography (50-80 words long) and high resolution (at least 300 dpi) photograph of the author(s) to accompany the article.


The publisher reserves the right to edit any article if necessary, whilst retaining its context.

We are not a peer-reviewed publication.

Once the article has been received by us, it is not our standard practice to send a proof back to the author prior to publication.

Your cooperation on these points will ensure that your article is included at the first available opportunity and reproduced to the highest possible standard.

If you have any further queries regarding the above, please contact the Editor, Caroline Peachey.

Media Planner/Content Calendar

Download our Media Planner & Content Calendar

    To download our Media Planner, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.